GRA_Logo

 + Home + About Us + Contact Us
 
+ Drug Delivery   + Monitoring & Diagnostics   + Healthcare    + Therapeutics    + Wound Care
 
Patient Controlled Analgesia
Products, Markets, Players and Outlook


About This Report

Price: US $3,850

Publication: Nov. 2011

Product Code: PCA477R




An increasing understanding of the physiology of pain coupled with patient-friendly dosage forms and delivery techniques is providing caregivers and prescribers with improved tools for helping patient manage their own pain. New and emerging pain delivery products that allow patients to play an active role in the timing and dosing of their pain medication - referred to as patient controlled analgesia (PCA) - allow patients to balance pain relief and medication side effects, and potentially improve quality-of-life. Pain management philosophy is based on the premise of treating pain early and aggressively. This is based on research that pain is tightly correlated with decreased quality of life, and increased incidence of anxiety and depression. Further, pain causes the physiologic release of destructive enzymes that can damage even healthy tissue. The aging population – particularly in North America and Western Europe, where the quality of medical care is high and consumers enjoy a relatively high standard of living – will create a growing market of mature and elderly needing drug therapies and pain management for a variety of maladies associated with the aging process. These factors are attracting well-financed players and elevating alliance activity in this sector.
Highlights

· Analyzes and evaluates devices and combination products for patient controlled anlagesia and assesses the market potential for existing and probable future products

· Examines patient controlled analgesia device design issues and evolving market factors

· Analylzes the impact of PCA technology and devices on drug delivery markets for pain management

· Provides market data and forecasts for PCA demand by market segment and region to 2015

• Profiles patient controlled analgesia market sector participants, their product development activity and business strategies

Summary of Contents
Executive Summary

Pain Management Market Dynamics
Tracking the Growth of PCA
Demand Drivers
Demographic Shifts
Evolving Pain Management Guidelines
Growth in Self-Administration
Technology Market Drivers
PCA Market Strategies

PCA Design Factors
Patient Usability
Medication Errors and Safety
Dose and Lockout Intervals
Bolus Dosing

PCA Device Assessments
Infusion Pumps
In-Patient/Bedside PCA Infusion
Ambulatory PCA Infusion
Development-Stage PCA Devices
Intranasal Sprays
Sublingual Sprays
Transdermal Devices
Pulmonary Inhalers

PCA Market Assessment
PCA Market Segments
In-Patient
Ambulatory
Home Care
PCA Indications
Trauma
Post-Operative/Obstetric Pain
Cancer Pain
Chronic Pain
Nociceptive Pain
Neuropathic Pain

Market Factors
Healthcare Regulations
Industry Standards
Managed Care Initiatives
Caregiver Training & Patient Monitoring

Market Data & Forecasts
North America
Europe
Japan
Other Geographies

Company Profiles





 

 

Recent Research

Patient Controlled Analgesia

Transdermal Drug Delivery

Drug Reconstitution Systems


Events

Radiology Society of North America (November 2011)

American College of Cardiology (March 2012)

American Association for Clinical Chemistry (July 2012)

World Congress on Glucose Monitoring and Insulin Delivery (April 2012)

 
     
 
Greystone Research Associates
98 Route 101A, Suite 17
Amherst, NH 03031 USA

Phone: 603-595-4340/ Fax: 603-218-7020
Copyright 2011 ·  Greystone Research Associates  ·  All Rights Reserved · Conditions of Use  ·  Career